Phase II Study of Heart Polypill in Primary Prevention of Cardiovascular Disease - Safety and Efficacy

Trial Profile

Phase II Study of Heart Polypill in Primary Prevention of Cardiovascular Disease - Safety and Efficacy

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Aspirin/hydrochlorothiazide/enalapril/atorvastatin (Primary)
  • Indications Cardiovascular disorders; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2010 Results published in the International Journal of Clinical Practice.
    • 24 Jun 2009 Trial phase changed from III to II, additional lead trial centre and investigator as reported by ClinicalTrials.gov.
    • 24 Jun 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top